GMP – Page 30 – Pharma.Tips

API site WHO GMP risk during internal gap assessment – avoiding repeat WHO observations

Navigating WHO GMP Risks in API Sites During Internal Gap Assessments Internal gap assessments at API sites are essential yet complex processes that critically determine compliance with WHO GMP standards.…

Extended cleaning duration during validation lifecycle – validated efficiency improvement

Addressing Extended Cleaning Duration During the Validation Lifecycle for Efficiency Improvement In pharmaceutical manufacturing, extended cleaning durations can significantly hinder operational efficiency, leading to potential compliance issues and costly downtime.…

WHO GMP gap identified during prequalification preparation – gap remediation roadmap

Addressing WHO GMP Gaps During Prequalification: A Comprehensive Remediation Roadmap Pharmaceutical manufacturers face constant scrutiny when preparing for WHO prequalification (PQ) evaluations, which assess compliance with Good Manufacturing Practices (GMP).…

Supplier WHO GMP non-compliance during WHO inspection – evidence pack for WHO audits

Addressing WHO GMP Non-Compliance during Inspections: A Practical Guide Pharmaceutical manufacturers face increasing scrutiny regarding compliance with Good Manufacturing Practices (GMP), especially during inspections by the World Health Organization (WHO).…

Documentation not aligned to WHO during prequalification preparation – gap remediation roadmap

Effective Remediation for Misaligned Documentation During WHO Prequalification In the pharmaceutical industry, misalignment of documentation with the World Health Organization (WHO) standards during prequalification can pose significant challenges, especially when…

Ineffective cleaning validation scope during CPV review – inspection-ready cleaning optimization

Optimizing Cleaning Validation Scope During CPV Review to Improve Inspection Readiness In pharmaceutical manufacturing, ineffective cleaning validation during the Continuous Process Verification (CPV) review can lead to significant regulatory compliance…

Inconsistent alignment with WHO TRS during internal gap assessment – gap remediation roadmap

Managing the Gap: Remediation Roadmap for WHO TRS Compliance Assessments Pharmaceutical manufacturers routinely assess compliance against the World Health Organization (WHO) Technical Report Series (TRS) as part of their internal…

API site WHO GMP risk during prequalification preparation – CAPA aligned to WHO standards

API Site WHO GMP Risk Management During Prequalification Preparation As pharmaceutical professionals, we understand the critical importance of compliance with WHO GMP standards during the prequalification (PQ) process. Inadequate preparation…

API site WHO GMP risk during API sourcing – gap remediation roadmap

“`html Mitigating WHO GMP Risks in API Sourcing: A Strategic Playbook In the pharmaceutical landscape, ensuring compliance with WHO GMP standards during Active Pharmaceutical Ingredient (API) sourcing is critical for…

Inefficient CIP cycle during equipment changeover – cycle time reduction with compliance assurance

Addressing Inefficiencies in CIP Cycles During Equipment Changeovers for Compliance and Performance A common challenge faced in pharmaceutical manufacturing is the inefficiency of Clean-In-Place (CIP) cycles during equipment changeovers. As…

Inconsistent alignment with WHO TRS during WHO inspection – avoiding repeat WHO observations

Addressing Inconsistent Alignment with WHO TRS Observations During Inspections As pharmaceutical manufacturers, consistency with World Health Organization (WHO) technical reports and guidelines is crucial for maintaining compliance during inspections. Inconsistencies…

API site WHO GMP risk during internal gap assessment – gap remediation roadmap

Addressing WHO GMP Risk in API Sites Through Internal Gap Assessment Remediation In the competitive landscape of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is paramount, especially for Active…